// App-Quantinova.ai

7035 : Prognostic significance of day 14 (D14) bone marrow (BM) assessment in adult patients receiving induction for Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL).

Researchers

Presenter

  • Nicholas James Short

Principal Investigators

  • Hagop M. Kantarjian

  • Koji Sasaki

  • Farhad Ravandi

  • Guillermo Garcia-Manero

  • Deborah A. Thomas

  • Sherry Pierce

  • Ghayas C. Issa

  • Jorge E. Cortes

  • Tapan M. Kadia

  • Nitin Jain

  • Susan Mary O'Brien

  • Elias Jabbour

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of California, Irvine, Fullerton, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved